US Stock MarketDetailed Quotes

CRVS Corvus Pharmaceuticals

Watchlist
  • 1.450
  • -0.030-2.03%
Close Apr 26 16:00 ET
  • 1.450
  • 0.0000.00%
Post 18:44 ET
71.11MMarket Cap-2589P/E (TTM)

About Corvus Pharmaceuticals Company

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in Burlingame, CA.

Company Profile

SymbolCRVS
Company NameCorvus Pharmaceuticals
Listing DateMar 23, 2016
Issue Price15.00
Founded2014
CEODr. Richard A. Miller,M.D.
MarketNASDAQ
Employees28
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address863 Mitten Road,Suite 102
CityBurlingame
ProvinceCalifornia
CountryUnited States of America
Zip Code94010
Phone1-650-900-4520
Websitehttp://www.corvuspharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Richard A. Miller,M.D.
  • President, Chief Executive Officer and Chairman of the Board
  • 524.24K
  • Leiv Lea
  • Chief Financial Officer and Principal Accounting Officer
  • 497.85K
  • William Benton Jones
  • Senior Vice President, Pharmaceutical Development
  • 455.54K
  • Elisha P. Gould, III
  • Independent Director
  • 73.80K
  • Scott W. Morrison
  • Independent Director
  • 81.80K
  • Dr. Linda S. Grais, J.D.,M.D.
  • Independent Director
  • 69.80K
  • Ian T. Clark
  • Independent Director
  • 65.80K
  • Dr. Peter A. Thompson,M.D.,F.A.C.P.
  • Independent Director
  • 67.80K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg